These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20616590)

  • 1. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
    Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system.
    Kudo K; Moriyasu F; Mine Y; Miyata Y; Sugimoto K; Metoki R; Kamamoto H; Suzuki S; Shimizu M; Miyahara T; Yokoi M; Horibe T; Yamagata H
    Eur J Radiol; 2007 Feb; 61(2):324-31. PubMed ID: 17049791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
    Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of CT-guided RFA for hepatocellular carcinoma].
    Takagi H; Ozeki I; Adachi Y; Hasegawa K; Iwata N; Kaneto H; Yamamoto H; Sasaki S; Imai K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1587-90. PubMed ID: 11707986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.